Ignite Creation Date:
2025-12-26 @ 12:16 PM
Ignite Modification Date:
2026-03-11 @ 11:06 PM
Study NCT ID:
NCT02290600
Status:
COMPLETED
Last Update Posted:
2018-07-12
First Post:
2014-08-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Feasibility Study Using Run-to-Run Control to Optimize Continuous Glucose Sensor Bias
Sponsor:
Sansum Diabetes Research Institute
Organization:
Study Overview
Official Title:
Feasibility Study Using Run-to-Run Control to Optimize Continuous Glucose Sensor Bias
Status:
COMPLETED
Status Verified Date:
2018-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this 12 week feasibility study is to see how much more accurate a continuous glucose monitor (CGM) might be in individuals with type 1 diabetes if the investigators personalize sensor calibrations to the user, based on previous wear.
Detailed Description:
The purpose of this 12 week study is to see how much more accurate a continuous glucose monitor (CGM) might be if we personalize the sensor calibration algorithm for each individual. The calibration algorithm is a mathematical calculation built into the CGM. Currently, the CGM asks for a regular blood test (finger stick) measurement twice a day in order to make its calibration algorithm more accurate. Our goal is to keep refining the calculating ability so that it will provide personalized blood sugar control throughout the day for each individual using the sensor with the CGM.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: